Recombinant Production of Ib-AMP<sub>4</sub> and Oncorhyncin II Antimicrobial Peptides and Antimicrobial Synergistic Assessment on the Treatment of Staphylococcus aureus Under In vitro Condition
Antimicrobial peptides (AMPs) have attracted significant interest owing to the growing intricacy of microbial infections. They constitute a promising category of novel antibiotics that warrant further investigation for the treatment of <i>S. aureus</i> infections and the enhancement of wound healing. Although certain AMPs can operate autonomously, others may necessitate a synergistic approach alongside conventional antibiotics. Studies examining the combined efficacy of Oncorhyncin II and Ib-AMP<sub>4</sub> against MRSA <i>in vitro</i> have revealed their effectiveness.
Authors
- Mina Safari (ORCID: https://orcid.org/0000-0003-4767-6596)
- Hamid Abtahi (ORCID: https://orcid.org/0000-0002-3247-3289)
- Shohreh Fahimirad (ORCID: https://orcid.org/0000-0002-9991-0869)
- Shima Chehreii (ORCID: https://orcid.org/0000-0001-6401-7897)
Institutions
- Arak University of Medical Sciences (IR)
- Islamic Azad University, Arak (IR)
Publication Details
- Journal
- Protein and Peptide Letters
- Published
- 2024-11-27
- DOI
- https://doi.org/10.2174/0109298665327474241112093601
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00